Prevalence, isotype, and functionality of antiheparin–platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia: The pathogenic role of IgG
- 15 January 2002
- journal article
- Published by Elsevier
- Vol. 105 (2) , 117-123
- https://doi.org/10.1016/s0049-3848(02)00004-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosisJournal of Laboratory and Clinical Medicine, 2001
- Determination of heparin–platelet factor 4–IgG antibodies improves diagnosis of heparin‐induced thrombocytopeniaBritish Journal of Haematology, 2001
- Induction of monocyte tissue factor expression by antibodies to heparin–platelet factor 4 complexes developed in heparin-induced thrombocytopeniaBlood, 2001
- Normal Life Expectancy and Thrombosis-Free Survival in Aspirin Treated Essential ThrombocythemiaClinical and Applied Thrombosis/hemostasis, 1999
- Effect of Glycoprotein IIb/IIIa Antagonists on the HIT Serum Induced Activation of PlateletsThrombosis Research, 1997
- Characterization of the humoral immune response in heparin-induced thrombocytopeniaAmerican Journal of Hematology, 1997
- A diagnostic test for heparin‐induced thrombocytopenia: detection of platelet microparticles using flow cytometryBritish Journal of Haematology, 1996
- Pathogenicity of IgA and/or IgM antibodies to heparin–PF4 complexes in patients with heparin‐induced thrombocytopeniaBritish Journal of Haematology, 1996
- On the Role of Platelet FcγRIIa Phenotype in Heparin-Induced ThrombocytopeniaThrombosis and Haemostasis, 1995
- Single amino acid mutation of FCγ receptor is associated with the development of heparin‐induced thrombocytopeniaBritish Journal of Haematology, 1995